US-China Biomedical Technology, Inc. Financing Cash Flow
US-China Biomedical Technology, Inc. reported Financing Cash Flow of $213.99 thousand for the 3-month period ending 2019-05-31, per its 10-Q filed 2019-07-22.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2019-07-22
- US-China Biomedical Technology, Inc. net cash provided by (used in) financing activities for the quarter ending 2019-05-31 was $213.99K, a 59.22% decline year-over-year.
- US-China Biomedical Technology, Inc. net cash provided by (used in) financing activities for the quarter ending 2019-02-28 was $0.00, a 100.00% decline year-over-year.
- US-China Biomedical Technology, Inc. net cash provided by (used in) financing activities for the quarter ending 2018-11-30 was $0.00, a 100.00% decline year-over-year.
- US-China Biomedical Technology, Inc. net cash provided by (used in) financing activities for the quarter ending 2018-08-31 was $0.00, a 100.00% decline year-over-year.
- US-China Biomedical Technology, Inc. net cash provided by (used in) financing activities for fiscal 2019 was $524.80K, a 15.61% increase from fiscal 2018.
- US-China Biomedical Technology, Inc. net cash provided by (used in) financing activities for fiscal 2018 was $453.93K, a 603.77% increase from fiscal 2017.
- US-China Biomedical Technology, Inc. net cash provided by (used in) financing activities for fiscal 2017 was $64.50K.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2019-05-31 | $213.99K 10-Q · filed 2019-07-22 | $213.99K derived: sum of 2 quarters · filed 2019-07-22 | $213.99K derived: sum of 3 quarters · filed 2019-07-22 | $213.99K derived: sum of 4 quarters · filed 2019-07-22 |
| 2019-02-28 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-06-12 | $0.00 derived: sum of 2 quarters · filed 2019-06-12 | $0.00 derived: sum of 3 quarters · filed 2019-06-12 | $524.80K 10-K · filed 2019-06-12 |
| 2018-11-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-01-10 | $0.00 derived: sum of 2 quarters · filed 2019-01-10 | $524.80K 10-Q · filed 2019-01-10 | $759.07K derived: sum of 4 quarters · filed 2019-07-22 |
| 2018-08-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-10-16 | $524.80K 10-Q · filed 2018-10-16 | $759.07K derived: sum of 3 quarters · filed 2019-07-22 | $813.74K derived: sum of 4 quarters · filed 2019-07-22 |
| 2018-05-31 | $524.80K 10-Q · filed 2019-07-22 | $759.07K derived: sum of 2 quarters · filed 2019-07-22 | $813.74K derived: sum of 3 quarters · filed 2019-07-22 | $978.74K derived: sum of 4 quarters · filed 2019-07-22 |
| 2018-02-28 | $234.26K derived: 10-K 12 month − 10-Q 9 month · filed 2019-06-12 | $288.93K derived: sum of 2 quarters · filed 2019-06-12 | $453.93K derived: sum of 3 quarters · filed 2019-06-12 | $453.93K 10-K · filed 2019-06-12 |
| 2017-11-30 | $54.67K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-01-10 | $219.67K derived: sum of 2 quarters · filed 2019-01-10 | $219.67K 10-Q · filed 2019-01-10 | $228.17K derived: sum of 4 quarters · filed 2019-01-10 |
| 2017-08-31 | $165.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-10-16 | $165.00K 10-Q · filed 2018-10-16 | $173.50K derived: sum of 3 quarters · filed 2018-10-16 | $179.50K derived: sum of 4 quarters · filed 2018-10-16 |
| 2017-05-31 | $0.00 10-Q · filed 2018-07-16 | $8.50K derived: sum of 2 quarters · filed 2018-07-16 | $14.50K derived: sum of 3 quarters · filed 2018-07-16 | |
| 2017-02-28 | $8.50K derived: 10-K 12 month − 10-Q 9 month · filed 2018-06-13 | $14.50K derived: sum of 2 quarters · filed 2018-06-13 | $64.50K 10-K · filed 2018-06-13 | |
| 2016-11-30 | $6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-01-18 | $56.00K 10-Q · filed 2018-01-18 | ||
| 2016-08-31 | $50.00K 10-Q · filed 2017-10-30 |